Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Inducing survivin in normal tissues can protect against radiation damage.

Six existing drugs may help block virus entry in COVID-19.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Rituximab can cause skin issues, but baricitinib may help improve them.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

AVT is highly conserved and may have antimicrobial properties.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.